StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$11.74−1.01 (-7.92%)

Close on Nov 17, 2026Market cap $79.70MP/E –Yield –

Eloxx Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Eloxx Pharmaceuticals's price to sales ratio was 0.0× on Feb 27, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 20260.0×−0.0
2025Dec 31, 20250.0×–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?